Please Wait a Moment
X

Articles

30May

Seasonal Monitoring for WNV to begin June 1, 2019

30 May, 2019 | Return|

Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin June 1 and continue through October 31, 2019. Should your facility have a reactive donation, CTS will send the WNV Alert email to inform you of your WNV reactive samples and request donor information. If you receive this email, please reply within 12 hours with the needed donor information (home city, state and zip code) as well as blood donation product type.

Again this year, CTS has distributed the 10 regional email groups (same as the 10 DHHS Regions) for you to notify other organizations serving overlapping and adjacent areas. In addition, you can access the most current reactive WNV sample information on the AABB West Nile Virus Biovigilance Network website.

Please contact your Customer Service Manager with any questions.

 

 

Related

Reminder- Check flights and cargo hours for the Memorial Day Holiday

As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...

Read More >

CTS Dallas and Phoenix Labs Implements WNV Testing on the Panther

CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...

Read More >

National Blood Donor Month

National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...

Read More >

Reminder- Check flights and cargo hours for the New Year's Day Holiday

As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...

Read More >

FDA Releases ZIKV Guidance and Grifols ZIKV Assay Licensed- August 8th Update

CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...

Read More >

Confirmatory Algorithm and Assay Changes Effective September 30, 2019

On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...

Read More >